Patent · US Active

Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof

US9815836B2 · kind B2 · utility

6Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 12, 2017
Grant dateNov 14, 2017
Priority date
Expiry dateJun 12, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D513/22
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.